Wolverine Trading’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.08M | Buy |
11,165
+7,499
| +205% | +$777K | ﹤0.01% | 2816 |
|
|
2025
Q2 | $391K | Sell |
3,666
-7,339
| -67% | -$743K | ﹤0.01% | 3190 |
|
|
2025
Q1 | $1.09M | Buy |
11,005
+4,729
| +75% | +$476K | ﹤0.01% | 2162 |
|
|
2024
Q4 | $563K | Sell |
6,276
-58,077
| -90% | -$5.11M | ﹤0.01% | 3268 |
|
|
2024
Q3 | $5.36M | Buy |
64,353
+42,741
| +198% | +$3.37M | 0.01% | 1002 |
|
|
2024
Q2 | $1.66M | Sell |
21,612
-4,714
| -18% | -$345K | ﹤0.01% | 1739 |
|
|
2024
Q1 | $1.8M | Sell |
26,326
-15,798
| -38% | -$1.02M | ﹤0.01% | 1690 |
|
|
2023
Q4 | $2.44M | Buy |
42,124
+6,030
| +17% | +$322K | ﹤0.01% | 1569 |
|
|
2023
Q3 | $1.91M | Buy |
36,094
+18,357
| +103% | +$963K | ﹤0.01% | 1627 |
|
|
2023
Q2 | $945K | Buy |
17,737
+9,744
| +122% | +$509K | ﹤0.01% | 2053 |
|
|
2023
Q1 | $396K | Buy |
7,993
+2,986
| +60% | +$141K | ﹤0.01% | 2738 |
|
|
2022
Q4 | $232K | Sell |
5,007
-17,854
| -78% | -$773K | ﹤0.01% | 2993 |
|
|
2022
Q3 | $899K | Buy |
22,861
+1,172
| +5% | +$47K | ﹤0.01% | 2066 |
|
|
2022
Q2 | $820K | Buy |
21,689
+583
| +3% | +$23.7K | ﹤0.01% | 2089 |
|
|
2022
Q1 | $943K | Sell |
21,106
-10,876
| -34% | -$471K | ﹤0.01% | 2499 |
|
|
2021
Q4 | $1.38M | Buy |
31,982
+5,286
| +20% | +$222K | ﹤0.01% | 2269 |
|
|
2021
Q3 | $1.17M | Sell |
26,696
-8,146
| -23% | -$360K | ﹤0.01% | 2791 |
|
|
2021
Q2 | $1.51M | Buy |
34,842
+8,861
| +34% | +$373K | ﹤0.01% | 2291 |
|
|
2021
Q1 | $1.01M | Buy |
+25,981
| New | +$983K | ﹤0.01% | 2748 |
|
|
2020
Q3 | – | Sell |
-13,867
| Closed | -$480K | – | 4523 |
|
|
2020
Q2 | $480K | Sell |
13,867
-14,665
| -51% | -$528K | ﹤0.01% | 2775 |
|
|
2020
Q1 | $903K | Sell |
28,532
-90,854
| -76% | -$3.55M | ﹤0.01% | 2029 |
|
|
2019
Q4 | $5.37M | Buy |
119,386
+69,473
| +139% | +$2.91M | 0.01% | 1041 |
|
|
2019
Q3 | $2.01M | Buy |
+49,913
| New | +$2.11M | 0.01% | 1433 |
|
|
2019
Q2 | – | Sell |
-5,449
| Closed | -$209K | – | 4431 |
|
|
2019
Q1 | $209K | Sell |
5,449
-26,918
| -83% | -$1.03M | ﹤0.01% | 3771 |
|
|
2018
Q4 | $1.12M | Buy |
+32,367
| New | +$1.17M | ﹤0.01% | 1871 |
|
|
2018
Q1 | – | Sell |
-78,967
| Closed | -$2.15M | – | 5106 |
|
|
2017
Q4 | $1.96M | Buy |
+78,967
| New | +$2.18M | 0.01% | 1574 |
|
|
2017
Q1 | – | Sell |
-46,004
| Closed | -$995K | – | 4291 |
|
|
2016
Q4 | $995K | Sell |
46,004
-16,022
| -26% | -$350K | ﹤0.01% | 1919 |
|
|
2016
Q3 | $1.45M | Buy |
62,026
+37,346
| +151% | +$891K | 0.01% | 1542 |
|
|
2016
Q2 | $568K | Buy |
+24,680
| New | +$534K | ﹤0.01% | 2107 |
|
Other funds holding BSX
Wolverine Trading's BSX Position: Q3 2025 in Review
Wolverine Trading increased its Boston Scientific (BSX) stake by 205% in Q3 2025, buying an estimated $777K and bringing the position to 11,165 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2816.
Wolverine Trading first reported a position in BSX in Q2 2016 and has held it in 29 quarters since. The position peaked at $5.37M in Q4 2019. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.
- Wolverine Trading held 11,165 shares of Boston Scientific worth $1.08M as of Q3 2025.
- Wolverine Trading bought 7,499 Boston Scientific shares in Q3 2025, an estimated $777K.
- Boston Scientific made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2816 holding.
- Wolverine Trading first reported a position in Boston Scientific in Q2 2016 and has held it in 29 quarters since.
- Wolverine Trading's Boston Scientific position peaked at $5.37M in Q4 2019.
- 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.